Abstract:Current methods for circulating tumor cell (CTC) detection are mostly include an enrichment step and the subsequent immunostaining-based identification of CTCs by epithelial and leukocytes markers. These methods are limited by loss and damage of CTCs during the enrichment and fail to determine the malignancy and drug targets of putative CTCs. We describe an enrichment-free, metabolic-based assay for rapid detection of tumor cells in the pleural effusion and peripheral blood samples. All nucleated cells are plated on microwell chips that contain 200,000 addressable microwells. These cells are labeled with a fluorescent anti-CD45 antibody (leukocyte marker), a fluorescent glucose analog (2-NBDG) and a dead cell marker (EthD-1). The microwell chips are imaged by a computerized high-speed fluorescent microscope in three colors and the bright filed. A computation algorithm analyzes the images and identify candidate tumor cells that are viable, CD45 negative, and exhibit high glucose uptake (EthD-1-/CD45-/2-NBDGhigh). A micromanipultor is then utilized to retrieve single tumor cells based on recorded addresses for single-cell sequencing. EthD-1-/CD45-/2-NBDG>100 cells are identified as candidate tumor cells. Single-cell sequencing based on a small panel of driver oncogenes (EGFR, KRAS, PIK3CA) shows that >60% of candidate tumor cells are true tumor cells harboring mutations in the panel. Single-cell whole exome sequencing results show all candidate tumor cells have high mutation frequency in dirver oncogenece and tumor suppressors from Qiagen's Human Lung Cancer Panel. Meanwhile, CD45-/EthD-1-/2-NBDG>100 tumor cells show heterogenieity in cytokeratin (CK) expression, and only ∼40% of these tumor cells are found CK positive. We have developed a simple and functional-based method to rapidly identify tumor cells with high glucose uptake in the clinical liquid samples without enrichment. These tumor cells are addressable, enabling single-cell manipulation and sequencing. Clinical feasibility of this assay has been established by testing samples from a cohort of patients.

Profiling Pleural Effusion Cells By A Diffraction Imaging Method

Differential Proteome Profiling of Pleural Effusions from Lung Cancer and Benign Inflammatory Disease Patients

Discovery of the correlation between the suspended membrane capacitance and adherent morphology of single cells enriching from clinical pleural effusion revealed by a microfluidic impedance flow cytometry

Two-Dimensional Quantitative Profiling of Cell Morphology with Serous Effusion by Unsupervised Machine Learning Analysis

Diagnosis of Serous Effusion with Intelligent Imaging Flow Cytometry

The expression levels of VEGF and ICAM-1 in pleural effusion

Exploring the value of pleural fluid biomarkers for complementary pleural effusion disease examination

[A Method for Isolating Tumor Cells from Large Volume of Malignant Pleural  Effusion and Its Efficacy Evaluation].

3D Cell Feature Measurement with a Diffraction Imaging Method.

A Quantitative Method for Measurement of HL-60 Cell Apoptosis Based on Diffraction Imaging Flow Cytometry Technique.

Separation of exfoliated tumor cells from viscoelastic pleural effusion using a microfluidic sandwich structure

Comparison Study of Distinguishing Cancerous and Normal Prostate Epithelial Cells by Confocal and Polarization Diffraction Imaging

Pattern Recognition and Classification of Two Cancer Cell Lines by Diffraction Imaging at Multiple Pixel Distances

Detection of effusion tumor cells under different storage and processing conditions

Celluar DNA Quantitative Analysis in Cytology for Clincal Application in Diagnosis

P2.01-001 Enrichment-Free, Rapid Metabolic Assay for Detection of Tumor Cells in Pleural Effusion and Pheripheral Blood: Topic: Analysis of Body Fluids in Cancer

Rapid analysis of white blood cells with diffraction imaging flow cytometry

Parallelized Bat Algorithm with a Communication Strategy

Analysis of Cellular Objects Through Diffraction Images Acquired by Flow Cytometry.

A rapid and convenient method for detecting a broad spectrum of malignant cells from malignant pleuroperitoneal effusion of patients using a multifunctional NIR heptamethine dye.

The investigation of the volatile metabolites of lung cancer from the microenvironment of malignant pleural effusion